Ribi Immunochem (ribi) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ribi Immunochem (ribi)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tom jones who wrote (61)	3/14/1998 12:24:00 PM
From: John	Read Replies (2) of 92

Jim McCamant's stated reason for changing the MTSL rec on RIBI to "sell over $5" was essentially that he was unhappy with the pace of progress at the company, and that, in his opinion, there were more attractive stocks in the biotech sector where the money could be used (his change of rec occurred a few months ago when all of the biotechs were at their lows). He did not criticize RIBI's products or mention any potential bad news. In fact, he stated that he believed that the milestones that were supposed to have occurred in 1997 would probably be reached in 1998, and of course, significantly, he did not put an outright sell on the stock (which was trading under $4 at the time), but rather recommended selling over $5, obviously indicating that he thought it would appreciate again. My reading was that he was basically frustrated with the pace at which management was moving, and that he is not negative on the products. Jim has been right many times, but he has also been wrong. I believe that RIBI can and will trade much higher. I have owned RIBI for years and will continue to hold.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next